Back to ProShare Advisors LLC ProShare Advisors LLC

ADMAADMA

Showing 9 of 27 quarters

Position history for ProShare Advisors LLCProShare Advisors LLC's holdings in ADMA Biologics Inc

Yes. ProShare Advisors holds 39,323 shares of ADMA (ADMA Biologics), worth $394,410, as of its Q3 2026 13F filing. It reduced the position by 1,195 shares (-3.0%) from Q2 2026. ProShare Advisors has held ADMA since Q4 2021, across 20 quarterly 13F filings.

Current Value

$394,410

Current Shares

39,323

Total Value Change

-$823,199

Total Shares Change

-21,588

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
39,323
-3.0%
$394,4100.0%$10.03
0
2026-Q2
Decreased
40,518
-13.4%
$339,1350.0%$8.37
0
2026-Q1
Decreased
46,794
-15.9%
$421,6140.0%$9.01
0
2025-Q4
Increased
55,655
+6.4%
$1M0.0%$18.24
27
2025-Q3
Decreased
52,293
-14.0%
$766,6170.0%$14.66
0
2025-Q2
Decreased
60,789
-6.3%
$1.1M0.0%$18.21
0
2025-Q1
Decreased
64,881
-18.2%
$1.3M0.0%$19.84
0
2024-Q4
Increased
79,286
+30.2%
$1.4M0.0%$17.15
32
2024-Q3
Increased
60,911
+42.1%
$1.2M0.0%$19.99
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used